Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 13;24(10):8711.
doi: 10.3390/ijms24108711.

Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities

Affiliations
Review

Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities

Theolan Adimulam et al. Int J Mol Sci. .

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a global pandemic, with an alarming infectivity and mortality rate. Studies have examined genetic effects on SARS-CoV-2 disease susceptibility and severity within Eurasian populations. These studies identified contrasting effects on the severity of disease between African populations. Genetic factors can explain some of the diversity observed within SARS-CoV-2 disease susceptibility and severity. Single nucleotide polymorphisms (SNPs) within the SARS-CoV-2 receptor genes have demonstrated detrimental and protective effects across ethnic groups. For example, the TT genotype of rs2285666 (Angiotensin-converting enzyme 2 (ACE2)) is associated with the severity of SARS-CoV-2 disease, which is found at higher frequency within Asian individuals compared to African and European individuals. In this study, we examined four SARS-CoV-2 receptors, ACE2, Transmembrane serine protease 2 (TMPRSS2), Neuropilin-1 (NRP1), and Basigin (CD147). A total of 42 SNPs located within the four receptors were reviewed: ACE2 (12), TMPRSS2 (10), BSG (CD147) (5), and NRP1 (15). These SNPs may be determining factors for the decreased disease severity observed within African individuals. Furthermore, we highlight the absence of genetic studies within the African population and emphasize the importance of further research. This review provides a comprehensive summary of specific variants within the SARS-CoV-2 receptor genes, which can offer a better understanding of the pathology of the SARS-CoV-2 pandemic and identify novel potential therapeutic targets.

Keywords: ACE2; CD147; COVID-19; NRP1; SARS-CoV-2; SNP; TMPRSS2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Polymorphisms within ACE2 (rs2285666), TMPRSS2 (rs12329760), NRP1 (rs10080), and CD147 (rs8259) contribute to variability in SARS-CoV-2 viral load. (A) Specific alleles facilitate viral entry and, thus, increased viral load, (B) while others disrupt protein function and reduce viral entry into the cell, resulting in lower viral load.
Figure 2
Figure 2
Inclusion and exclusion criteria used to select SNPs discussed in this review for SARS-CoV-2 receptors and co-receptors ACE2, TMPRSS2, NRP1, and BSG(CD147) genes.

References

    1. Patel R., Kaki M., Potluri V.S., Kahar P., Khanna D. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Hum. Vaccines Immunother. 2022;18:2002083. - PMC - PubMed
    1. Rodriguez E.V., Bouazza F.-Z., Dauby N., Mullier F., D’otreppe S., Jissendi Tchofo P., Bartiaux M., Sirjacques C., Roman A., Hermans C. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: First documented case outside US. Infection. 2022;50:531–536. doi: 10.1007/s15010-021-01712-8. - DOI - PMC - PubMed
    1. Wang C., Liu B., Zhang S., Huang N., Zhao T., Lu Q.B., Cui F. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review. J. Med. Virol. 2023;95:e28118. doi: 10.1002/jmv.28118. - DOI - PMC - PubMed
    1. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapouméroulie C., Cognaux J., Forceille C. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722–725. doi: 10.1038/382722a0. - DOI - PubMed
    1. De Silva E., Stumpf M.P.H. HIV and the CCR5-Δ32 resistance allele. FEMS Microbiol. Lett. 2004;241:1–12. doi: 10.1016/j.femsle.2004.09.040. - DOI - PubMed

Substances